Neoadjuvant chemotherapy of locally advanced breast cancer: Historical comparison of 4 sequential combinations;Etude comparative de 4 protocoles successifs de chimiotherapie premiere dans le cancer du sein localement avance

Bulletin du Cancer

Volumn 84, Issue 1, 1997, Pages 10-16

  Ferrero, Jean Marc ^a   Namer, Moïse ^a   Dufour, Jean Francois ^a   Largillier, Rémy ^a   Creisson, Anne ^a   Teissier, Eric ^a   Machiavello, Jean Christophe ^a   Lallement, Michel ^a   Monticelli, Jean ^a   Abbes, Michel ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

breast cancer; neoadjuvant chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; NAVELBINE; PREDNISONE; VINCRISTINE; VINDESINE;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; SURVIVAL;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUTROPENIA; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 8044260251     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Anderson ED, Forrest AP, Hawkins RA, Anderson TJ, Leonard RC, Chetty U. Primary systemic therapy for operable breast cancer. Br J Cancer 1991; 63: 561-6.
2. Belembaogo E, Feillel U, Chollet P, Cure H, Verrelle P, Kwiatkowski F. Neoadjuvant chemotherapy in 126 operable breast cancer. Eur J Cancer 1992; 28: 896-900.
3. Bonnadonna G, Veronesi U, Valagussa P. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 1990; 82: 1539-45.
4. Cocconi G, Di Blasio B, Bisagni G. Neoadjuvant chemotherapy or chemotherapy and endocrine therapy in locally advanced breast carcinoma. Am J Clin Oncol 1990; 13: 226-32.
5. Fisher B, Bauer M, Margolese R. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985; 312: 655-73.
6. Fisher B, Mamounas EP. Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. J Clin Oncol 1995; 13: 537-40.
7. Fisher B, Saffer EA, Rudock C. Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res 1989; 49: 1996-2001.
8. Fisher B, Rockette H, Robidoux A, Margolese R, Cruz A, Hoehn J. Effect of preoperative therapy for breast cancer on local regional disease: first report of NSABP B-18. Proc Am Soc Clin Oncol 1994; 13: 64.
9. Gardin G, Alama A, Rosso R, Campora E, Repetto L, Pronzato P, Merlini L, Naso C, Camoriano A, Meazza R. Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer. Breast Cancer Res Treat 1994; 32: 311-8.
10. Goldie JH, Coldman AJ. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979; 63: 1727-33.
11. Henderson IC. Chemotherapy for metastatic disease. In: Harris JR, Hellman S, Henderson IC, Kinne DW, eds. Breast diseases. 2nd edition, Philadelphia: JB Lippincott Compagny, 1991: 604-65.
12. Heys SD, Eremin JM, Sarkar TK, Hutcheon AW, Ahsee A, Eremin O. Role of multimodality therapy in the management of locally advanced carcinoma of the breast. J Am Coll Surgeons 1994; 179: 493-504.
13. Hortobagyi GN, Ames FC, Buzdar AU. Management of stage III primary breast cancer with primary chemotherapy, surgery and radiation therapy. Cancer 1988; 62: 2507-16.
14. Jacobson JA, Danfouth DN, Cowan KH, D'Aangelo T, Steinberg SM, Pierce L, Lippmann, HE, Lichter AS, Glatstein E, Okunief P. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995; 332: 907-11.
15. Jacquillat C, Weil M, Bailet F. Results of neoadjuvant chemotherapy and radiation therapy in the breast conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 1990; 66: 119-29.
16. Kantarjian HM, Hortobagyi GN, Smith TL. The management of locally advanced breast cancer: a combined modality approach. Eur J Cancer Clin Oncol 1984; 20: 1353-61.
17. Mauriac L, Durand M, Avril A, Dilhuydy JM. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. Ann Oncol 1991; 2: 347-54.
18. Morris DM, Edwards J, Gelder F. Hormonal receptors in locally advanced breast cancer: change with response to neoadjuvant chemotherapy. J Surg Oncol 1991; 46: 156-8.
19. Nissen-Meyer R, Host H, Kjellgren K. Scandinavian trials with a short post-operative course versus a 12-cycle course. Recent Results Cancer Res 1984; 96: 48-54.
20. Perloff M, Lesnick J. Chemotherapy before and after mastectomy in stade III breast cancer. Arch Surg 1982; 117: 879-81.
21. Powles TJ, Hickish TF, Makris A, Ashley SE, O'Brien ME, Tidy VA, Casey S, Nash AG, Sacks N. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 1995; 13: 547-52.
22. Remvikos Y, Jouve M, Beuzeboc P, Viehl P, Magdalenat H, Pouillart P. Cell cycle modifications of breast cancer during neoadjuvant chemotherapy: a flow cytometry study on five needle aspirates. Eur J Cancer 1993; 29: 1843-8.
23. Sauter ER, Eisenberg BL, Hoffman TP, Ottery FD, Boraas MC, Goldstein LJ, Solin LJ. Post mastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer. World J Surg 1993; 17: 237-42.
24. Scholl SM, Fourquet A, Asselain B, Pierga JY, Vilcoq JR, Durand JC, Dorval T, Palangie T, Jouve M, Beuzeboc P, et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomized trial. Eur J Cancer 1994; 30A: 645-52.
25. Skipper HE. Kinetics of mammary tumor cell growth and implications for therapy. Cancer 1971; 28: 1479-99.
26. Smith IE, Jones AL, O'Brien MER. Primary medical (neo-adjuvant) chemotherapy for operable breast cancer. Eur J Cancer 1993; 29A: 1796-9.
27. Spielmann M, Dorval T, Turpin F, Antoine E, Jouve M, May-Levin F, Lacombe D, Rouesse J, Pouillart P, Tursz, et al. Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer. J Clin Oncol 1994; 12: 1764-70.
28. Swain SM, Sorace RA, Lippman LE. Neoadjuvant chemotherapy in the combined modality approach of locally advanced non metastatic breast cancer. Cancer Res 1987; 47: 3889-94.
29. The Ludwig Cancer Study Group. Prolonged disease-free survival after one course of peri-operative adjuvant chemotherapy for node-negative breast cancer. N Eng J Med 1989; 320: 491-6.
30. Veronesi U, Banfi A, Del Vecchio M. Comparison of haldsted mastectomy with quadrantectomy axillary dissection and radiotherapy in early breast cancer: long term results. Eur J Cancer Clin Oncol 1986; 22: 1085-9.
31. Yap HY, Blumenschein GR, Hortobagyi GN. A randomized comparative study of vinblastine, vindesine and vincristine in patients with refractory breast cancer. Proc Am Soc Clin Oncol 1981; 22: 441.